131 related articles for article (PubMed ID: 2507321)
21. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
22. Circle of Willis blood flow patterns in healthy newborn infants.
Raju TN; Kim SY; Chapman L
J Pediatr; 1989 Mar; 114(3):455-8. PubMed ID: 2646417
[No Abstract] [Full Text] [Related]
23. Artificial surfactant therapy in hyaline-membrane disease.
Fujiwara T; Maeta H; Chida S; Morita T; Watabe Y; Abe T
Lancet; 1980 Jan; 1(8159):55-9. PubMed ID: 6101413
[TBL] [Abstract][Full Text] [Related]
24. Instillation rate effects of Exosurf on cerebral and cardiovascular haemodynamics in preterm neonates.
Saliba E; Nashashibi M; Vaillant MC; Nasr C; Laugier J
Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F174-8. PubMed ID: 7820712
[TBL] [Abstract][Full Text] [Related]
25. Arterial blood pressure and blood flow velocity in major cerebral and visceral arteries. I. Interindividual differences.
Kempley ST; Gamsu HR
Early Hum Dev; 1993 Oct; 34(3):227-32. PubMed ID: 8287807
[TBL] [Abstract][Full Text] [Related]
26. Carbon dioxide reactivity of the cerebral circulation in extremely premature infants: effects of postnatal age and indomethacin.
Levene MI; Shortland D; Gibson N; Evans DH
Pediatr Res; 1988 Aug; 24(2):175-9. PubMed ID: 3141892
[TBL] [Abstract][Full Text] [Related]
27. Exogenous surfactant replacement therapy of hyaline membrane disease in premature infants.
Namgung R; Lee C; Suh JS; Park KI; Han DG
Yonsei Med J; 1989 Dec; 30(4):355-66. PubMed ID: 2697112
[TBL] [Abstract][Full Text] [Related]
28. One-year follow-up of 66 premature infants weighing 500 to 699 grams treated with a single dose of synthetic surfactant or air placebo at birth: results of a double-blind trial. American Exosurf Neonatal Study Group I.
Walther FJ; Mullett M; Schumacher R; Sundell H; Easa D; Long W
J Pediatr; 1995 May; 126(5 Pt 2):S13-9. PubMed ID: 7745506
[TBL] [Abstract][Full Text] [Related]
29. Effect of single dose surfactant on pulmonary function.
Bhat R; Dziedzic K; Bhutani VK; Vidyasagar D
Crit Care Med; 1990 Jun; 18(6):590-5. PubMed ID: 2111754
[TBL] [Abstract][Full Text] [Related]
30. [Effect of a bovine surfactant in very low birth weight premature infants with congenital pneumonia].
Gortner L; Pohlandt F; Bartmann P
Monatsschr Kinderheilkd; 1990 May; 138(5):274-8. PubMed ID: 2377170
[TBL] [Abstract][Full Text] [Related]
31. [Age-dependent blood flow velocity in the cerebral arteries of newborn infants and infants measured by Doppler sonography].
Rupprecht T; Deeg KH; Zeilinger G
Ultraschall Med; 1988 Apr; 9(2):76-83. PubMed ID: 3399872
[TBL] [Abstract][Full Text] [Related]
32. Very early surfactant without mandatory ventilation in premature infants treated with early continuous positive airway pressure: a randomized, controlled trial.
Rojas MA; Lozano JM; Rojas MX; Laughon M; Bose CL; Rondon MA; Charry L; Bastidas JA; Perez LA; Rojas C; Ovalle O; Celis LA; Garcia-Harker J; Jaramillo ML;
Pediatrics; 2009 Jan; 123(1):137-42. PubMed ID: 19117872
[TBL] [Abstract][Full Text] [Related]
33. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
Couser RJ; Ferrara TB; Ebert J; Hoekstra RE; Fangman JJ
J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
[TBL] [Abstract][Full Text] [Related]
34. Acute effects of acetazolamide on cerebral blood flow velocity and pCO2 in the newborn infant.
Cowan F; Whitelaw A
Acta Paediatr Scand; 1991 Jan; 80(1):22-7. PubMed ID: 1903018
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular support for low birth weight infants and cerebral hemodynamics: a randomized, blinded, clinical trial.
Pellicer A; Valverde E; Elorza MD; Madero R; Gayá F; Quero J; Cabañas F
Pediatrics; 2005 Jun; 115(6):1501-12. PubMed ID: 15930210
[TBL] [Abstract][Full Text] [Related]
36. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants.
Kwong MS; Egan EA; Notter RH; Shapiro DL
Pediatrics; 1985 Oct; 76(4):585-92. PubMed ID: 3900906
[TBL] [Abstract][Full Text] [Related]
37. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity.
Merritt TA; Hallman M; Berry C; Pohjavuori M; Edwards DK; Jaaskelainen J; Grafe MR; Vaucher Y; Wozniak P; Heldt G
J Pediatr; 1991 Apr; 118(4 Pt 1):581-94. PubMed ID: 2007937
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two strategies for surfactant prophylaxis in very premature infants: a multicenter randomized trial.
Kendig JW; Ryan RM; Sinkin RA; Maniscalco WM; Notter RH; Guillet R; Cox C; Dweck HS; Horgan MJ; Reubens LJ; Risemberg H; Phelps DL
Pediatrics; 1998 Jun; 101(6):1006-12. PubMed ID: 9606227
[TBL] [Abstract][Full Text] [Related]
39. Cerebral blood flow velocity changes after rapid administration of surfactant.
Cowan F; Whitelaw A; Wertheim D; Silverman M
Arch Dis Child; 1991 Oct; 66(10 Spec No):1105-9. PubMed ID: 1750756
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary and systemic arterial pressure in hyaline membrane disease.
Skinner JR; Boys RJ; Hunter S; Hey EN
Arch Dis Child; 1992 Apr; 67(4 Spec No):366-73. PubMed ID: 1586172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
